Personalis (PSNL) News Today $3.11 -0.19 (-5.76%) Closing price 04:00 PM EasternExtended Trading$3.12 +0.01 (+0.32%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period AIGH Capital Management LLC Sells 200,000 Shares of Personalis, Inc. (NASDAQ:PSNL)AIGH Capital Management LLC trimmed its stake in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 5.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,799,064 shares of the company's stock after selling 200,000 sharesMarch 31, 2025 | marketbeat.comPersonalis initiated with a Buy at Craig-HallumMarch 18, 2025 | markets.businessinsider.comCraig-Hallum Initiates Coverage of Personalis (PSNL) with Buy RecommendationMarch 18, 2025 | msn.comBTIG Reaffirms Their Buy Rating on Personalis (PSNL)March 18, 2025 | markets.businessinsider.comPersonalis (NASDAQ:PSNL) Earns Buy Rating from Analysts at Craig HallumCraig Hallum began coverage on Personalis in a report on Monday. They issued a "buy" rating and a $8.00 price target on the stock.March 18, 2025 | marketbeat.comCraig-Hallum bullish on Personalis, initiates with a BuyMarch 17, 2025 | markets.businessinsider.comNew Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence DetectionMarch 3, 2025 | businesswire.comPersonalis FY2029 EPS Forecast Lowered by HC WainwrightPersonalis, Inc. (NASDAQ:PSNL - Free Report) - Investment analysts at HC Wainwright reduced their FY2029 EPS estimates for Personalis in a research report issued to clients and investors on Friday, February 28th. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn $0.33March 3, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $8.00 target price on shares of Personalis in a research note on Friday.March 1, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLCNeedham & Company LLC lowered their target price on Personalis from $7.25 to $7.00 and set a "buy" rating for the company in a research report on Friday.March 1, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Announces Quarterly Earnings ResultsPersonalis (NASDAQ:PSNL - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.23) EPS for the quarter, beating analysts' consensus estimates of ($0.32) by $0.09. Personalis had a negative return on equity of 66.07% and a negative net margin of 104.52%.February 28, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPSPersonalis (NASDAQ:PSNL - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.32) by $0.09. Personalis had a negative return on equity of 66.07% and a negative net margin of 104.52%.February 28, 2025 | marketbeat.comPersonalis Reports 2024 Growth and Strategic PartnershipsFebruary 27, 2025 | tipranks.comPersonalis sees FY25 revenue $80M-$90M, consensus $84.65MFebruary 27, 2025 | markets.businessinsider.comPersonalis sees Q1 revenue $17M-$18M, consensus $16.25MFebruary 27, 2025 | markets.businessinsider.comPersonalis, Inc. (PSNL) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comPersonalis Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 27, 2025 | businesswire.comARK Investment Management LLC Has $39.16 Million Position in Personalis, Inc. (NASDAQ:PSNL)ARK Investment Management LLC reduced its holdings in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,775,435 shares of the company's stock after selling 3February 26, 2025 | marketbeat.comPersonalis (PSNL) Projected to Post Earnings on WednesdayPersonalis (NASDAQ:PSNL) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=514524)February 19, 2025 | marketbeat.comPersonalis to Participate at the TD Cowen's 45th Annual Health Care ConferenceFebruary 18, 2025 | finance.yahoo.comSumitomo Mitsui Trust Group Inc. Sells 59,295 Shares of Personalis, Inc. (NASDAQ:PSNL)Sumitomo Mitsui Trust Group Inc. reduced its position in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 7.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 733,313 shares of the company's stock after selling 59,295 shares during the period. SumitomoFebruary 14, 2025 | marketbeat.comPersonalis to Announce Fourth Quarter and Full Year 2024 Financial ResultsFebruary 14, 2025 | finance.yahoo.comabrdn plc Invests $1.72 Million in Personalis, Inc. (NASDAQ:PSNL)abrdn plc acquired a new position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 297,889 shares of the company's stock, valued at approximately $1,722,000.February 11, 2025 | marketbeat.comFY2024 EPS Estimates for Personalis Reduced by HC WainwrightPersonalis, Inc. (NASDAQ:PSNL - Free Report) - Stock analysts at HC Wainwright dropped their FY2024 earnings per share (EPS) estimates for shares of Personalis in a research note issued on Monday, January 27th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings perJanuary 29, 2025 | marketbeat.comPersonalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 28, 2025 | finance.yahoo.comAnalysts Set Expectations for Personalis FY2029 EarningsPersonalis, Inc. (NASDAQ:PSNL - Free Report) - Research analysts at HC Wainwright issued their FY2029 earnings per share estimates for Personalis in a research note issued on Monday, January 27th. HC Wainwright analyst S. Ramakanth anticipates that the company will earn $0.35 per share for the yeJanuary 28, 2025 | marketbeat.comPositive Outlook for Personalis Driven by Strategic Collaborations and Innovative Testing ProductsJanuary 27, 2025 | markets.businessinsider.comPersonalis stock price target cut to $8 by H.C. WainwrightJanuary 27, 2025 | msn.comPersonalis price target lowered to $8 from $11 at H.C. WainwrightJanuary 27, 2025 | msn.comHC Wainwright Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock PriceHC Wainwright cut their target price on shares of Personalis from $11.00 to $8.00 and set a "buy" rating for the company in a research note on Monday.January 27, 2025 | marketbeat.comPersonalis publishes results from TRACERx lung cancer study in Nature MedicineJanuary 14, 2025 | markets.businessinsider.comLake Street Sticks to Their Buy Rating for Personalis (PSNL)January 13, 2025 | markets.businessinsider.comNew Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung CancerJanuary 13, 2025 | businesswire.comBuy Rating for Personalis Driven by Strong Biopharma Revenue Growth and Promising Future ProspectsJanuary 9, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Personalis (PSNL)January 9, 2025 | markets.businessinsider.comPromising Outlook for Personalis: Buy Rating Supported by Strong Financial Performance and Strategic PositioningJanuary 9, 2025 | markets.businessinsider.comPersonalis (NASDAQ:PSNL) Price Target Raised to $9.00Lake Street Capital upped their price objective on shares of Personalis from $7.00 to $9.00 and gave the company a "buy" rating in a research note on Wednesday.January 8, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Personalis (NASDAQ:PSNL)HC Wainwright reaffirmed a "buy" rating and set a $11.00 target price on shares of Personalis in a research report on Wednesday.January 8, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Personalis (NASDAQ:PSNL)Needham & Company LLC reissued a "buy" rating and set a $7.25 target price on shares of Personalis in a research report on Wednesday.January 8, 2025 | marketbeat.comPersonalis Reports Preliminary Fourth Quarter and Full Year 2024 RevenueJanuary 7, 2025 | finance.yahoo.comPersonalis up 3% at $6.15 after Q4 pre-announcement, FY24 guidance increaseJanuary 7, 2025 | markets.businessinsider.comStrong Performance and Strategic Investment Justify Buy Rating for PersonalisJanuary 7, 2025 | markets.businessinsider.comJane Street Group LLC Increases Stock Position in Personalis, Inc. (NASDAQ:PSNL)Jane Street Group LLC lifted its holdings in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 154.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 164,281 shares of the company's stock after buying an additional 99,671 shares during the perioJanuary 2, 2025 | marketbeat.comLocal vaccine biotech secures $50 million Merck investmentDecember 26, 2024 | bizjournals.comThe 16% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 159%December 26, 2024 | finance.yahoo.comLocal vaccine biotech secures $50M Merck investmentDecember 24, 2024 | bizjournals.comPersonalis (PSNL) Gets a Buy from BTIGDecember 22, 2024 | markets.businessinsider.comPersonalis Receives Buy Rating Amid Strategic Investments and Revenue Growth PotentialDecember 22, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Personalis (PSNL)December 20, 2024 | markets.businessinsider.comPersonalis price target raised to $11 from $9 at H.C. WainwrightDecember 20, 2024 | markets.businessinsider.com Remove Ads Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address PSNL Media Mentions By Week PSNL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSNL News Sentiment▼1.760.61▲Average Medical News Sentiment PSNL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSNL Articles This Week▼12▲PSNL Articles Average Week Remove Ads Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VRDN News Today AVAH News Today CDNA News Today PNTG News Today GRAL News Today FTRE News Today CSTL News Today AUNA News Today FLGT News Today EHAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSNL) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PSNL Stock Free PSNL Stock Alerts